RTW INVESTMENTS LLC 13D and 13G filings for Fulcrum Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 06:15 am Sale | 2024-09-30 | 13G | Fulcrum Therapeutics, Inc. FULC | RTW INVESTMENTS LLC | 0 0.000% | -5,469,956 (Position Closed) | Filing |
| 2024-02-14 07:53 am Purchase | 2023-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | RTW INVESTMENTS LLC | 5,469,956 8.800% | 476,677 (+9.55%) | Filing |
| 2023-02-14 10:04 am Purchase | 2022-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | RTW INVESTMENTS LLC | 4,993,279 9.600% | 1,126,407 (+29.13%) | Filing |
| 2022-02-14 08:22 am Purchase | 2021-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | RTW INVESTMENTS LLC | 3,866,872 9.500% | 1,795,463 (+86.68%) | Filing |
| 2021-02-12 10:12 am Unchanged | 2020-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | RTW INVESTMENTS LLC | 2,071,409 7.540% | 0 (Unchanged) | Filing |
| 2020-11-13 09:57 am Purchase | 2020-11-03 | 13G | Fulcrum Therapeutics, Inc. FULC | RTW INVESTMENTS LLC | 2,071,409 7.550% | 2,071,409 (New Position) | Filing |